Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000009

President and CEO gave up 20,730 shares (to pay taxes)

  • President and CEO acquired 50,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-12 Grant or award : show line 1 in the form +14,400 615,924 D
2019-02-12 Grant or award : show line 2 in the form +36,000 651,924 D
2019-02-12 Shares withheld for taxes : show line 3 in the form −20,730 $88.88 $1,842,482 631,194 D
Loading xslF345X03/edgar.xml…